A new microfluidic chip that mimics the human spleen has given researchers a closer look into one of the complications of sickle cell disease.
Sickle cell disease is a genetic condition that affects hemoglobin, the protein in red blood cells that carries oxygen. Abnormal hemoglobin causes red blood cells to stiffen and develop a sickle shape, making them less effective at carrying oxygen and more prone to clogging small blood vessels. One of the most dangerous side effects of sickle cell disease is acute splenic sequestration, a painful clogging of the spleen that often requires the organ to be removed.
While researchers knew that acute splenic sequestration likely involved the clogging of the spleen by sickled red blood cells, there was no way to watch this process evolve in real human tissue. Nor is it entirely clear why some people with sickle cell experience this crisis and others don’t. According to a 1985 study in the Journal of Pediatrics, only about 20% of people with sickle cell disease experience acute splenic sequestration, usually in early childhood.
Ming Dao, a principal research scientist in the Dept. of Materials Science and Engineering at the Massachusetts Institute of Technology (MIT), and his colleagues developed a “spleen on a chip” to probe the dynamics of acute splenic sequestration. This miniature device consists of two...
Would you like to access the complete CEP News Update?
No problem. You just have to complete the following steps.
You have completed 0 of 2 steps.
-
Log in
You must be logged in to view this content. Log in now.
-
AIChE Membership
You must be an AIChE member to view this article. Join now.
Copyright Permissions
Would you like to reuse content from CEP Magazine? It’s easy to request permission to reuse content. Simply click here to connect instantly to licensing services, where you can choose from a list of options regarding how you would like to reuse the desired content and complete the transaction.